FDA regulation related Press Releases
FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene
FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene The U.S. Food and Drug Administration is taking several actions to reduce the risk of overdose in patients using pain... Read more...
FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban
FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban The U.S. Food and Drug Administration today announced that it is requiring manufacturers to put a Boxed Warning... Read more...
Merck Statement in Response to FDA's June Communication with Updated Information on Leukotriene Inhibitors, Including Singulair
Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR® (montelukast sodium)
WHITEHOUSE STATION,... Read more...
FDA Requests Labeling Change for Leukotriene Modifiers
FDA Requests Labeling Change for Leukotriene Modifiers The U.S. Food and Drug Administration today provided further updated safety information on a class of asthma drugs known as leukotriene... Read more...
Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma a
Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma HOUSTON, May 19 /PRNewswire/ -- Agennix announced today that talactoferrin... Read more...
Stem Cell Therapeutics Corp. Announces the FDA Has Lifted Its Clinical Hold on the Phase IIb Stroke Trial
Stem Cell Therapeutics Corp. Announces the FDA Has Lifted Its Clinical Hold on the Phase IIb Stroke Trial CALGARY, ALBERTA--(Marketwire - May 14, 2009) - Stem Cell Therapeutics Corp. ("SCT" or "the... Read more...
FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely
FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely The Food and Drug Administration issued a final rule today that requires
... Read more...FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to Swine Flu Outbreak in Humans
FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to Swine Flu Outbreak in Humans The U.S. Food and Drug Administration, in response to requests from the U.S. Centers
... Read more...KV Pharmaceutical Enters Into Consent Decree With FDA
KV Pharmaceutical Enters Into Consent Decree With FDA Decree outlines path forward to resume manufacturing at KV facilities ST. LOUIS, March 2 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company
... Read more...FDA Takes New Regulatory Action Against Ranbaxy's Paonta Sahib Plant in India
FOR IMMEDIATE RELEASEFeb. 25, 2009
Media Inquiries: Christopher Kelly, 301-796-4676 or 240-753-8610Consumer Inquiries: 888-INFO-FDA
FDA Takes New Regulatory Action Against Ranbaxy's
... Read more...Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
